The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. 1989

R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
MRC Brain Metabolism Unit, Royal Edinburgh Hospital.

Single photon emission tomography (SPET) with the lipophilic blood flow marker 99mTc-hexamethyl propyleneamine oxime (99mTc-HMPAO) has been used to determine regional uptake of radiolabel into brain regions of patients with presenile Alzheimer's disease and Korsakoff's psychosis, and age-matched controls. Using occipital cortical uptake as reference area, the pattern of relative regional cerebral blood flow (rCBF) was determined in other cortical areas and basal ganglia. In Alzheimer's disease, reduction in rCBF occurred most strikingly in posterior temporal and parietal areas. By contrast, in Korsakoff's psychosis, posterior temporal rCBF was maintained, although there was a trend to reduced tracer uptake in other cortical areas. These impairments of flow were correlated with impairments of neuropsychological function. In Alzheimer's disease, left posterior temporal and left parietal regions in particular showed rCBF to be strongly correlated with most aspects of cognitive function. In Korsakoff's psychosis, however, impaired flow in frontal regions was correlated with impaired performance on tests of memory and orientation. The findings in Alzheimer's disease show quantitative parallels with those from studies using Positron Emission Tomography (PET), and extend our understanding of the relationship between cognition and regional brain function in dementia. The findings in Korsakoff's psychosis offer the first direct evidence linking frontal lobe dysfunction with the cognitive impairment seen in the disorder.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
June 1993, Acta psychiatrica Scandinavica,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
March 1999, European journal of nuclear medicine,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
January 1992, European journal of nuclear medicine,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
May 1994, Psychological medicine,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
September 1998, European journal of nuclear medicine,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
September 1989, Acta neurologica Scandinavica,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
January 1992, European journal of nuclear medicine,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
January 1983, Journal of neuroradiology = Journal de neuroradiologie,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
January 1990, European neurology,
R Hunter, and R McLuskie, and D Wyper, and J Patterson, and J E Christie, and D N Brooks, and J McCulloch, and G Fink, and G M Goodwin
January 1995, Journal of neural transmission. Parkinson's disease and dementia section,
Copied contents to your clipboard!